Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Treasure trove for research and therapy

03.11.2014

They are termed adhesion G protein-coupled receptors. These receptors are involved in a wealth of vital functions in the body and therefore represent a promising target for drugs, yet relatively little is known about how they work. A new research unit is keen to change this.

Seeing, smelling, tasting, when the heart beats, when hormones do their job – during all these processes, and many others, important tasks are undertaken by a certain class of receptors, known as G protein-coupled receptors, or GPCRs for short.


Dr. Tobias Langenhan, head of the new DFG research unit “Elucidation of Adhesion-GPCR Signaling”.

Photo: Gunnar Bartsch

Hundreds of them are encoded in the human genome and sit on the surface of cells, where they receive signals, which they transfer to the cell interior. One indication of their importance is the fact that around half of all clinically approved drugs target these receptors and, in doing so, treat ailments as varied as, for example, hypertension, asthma, and Parkinson’s disease. So, from a scientific perspective, these receptors are “a treasure trove” for the development of new therapeutics.

The new research unit

Adhesion GPCRs form a sub-group of this receptor class. They are the focus of a new research unit that has now been approved by the German Research Foundation (DFG). Its spokesperson is the Würzburg medic and neurobiologist Dr. Tobias Langenhan.

The team includes scientists from the universities of Würzburg, Leipzig, Mainz, Erlangen-Nuremberg, and the Amsterdam Medical Center of the University of Amsterdam. By pooling their expertise in this field it is hoped that they will break new ground together. The DFG will be contributing around two million euros to fund the project over the next three years; an extension of a further three years is possible.

“What do they feel? How do they translate stimuli into a cellular response? And what happens when they are missing?” The scientists involved in the research unit want to find answers to these three questions over the next few years, explains Tobias Langenhan.

There are 33 varieties of adhesion GPCRs in the human body. They are important control centers in the brain and in the immune system; they play a significant role in the development of the heart and blood vessels as well as in other processes. And, although they are among the oldest and largest surface proteins in humans, the way in which they work is still largely a mystery.

When receptors are missing

“We now know a little about what happens when they are missing in certain areas of the body,” says Langenhan. This can cause, for example, the development of Usher syndrome, a common congenital hearing and visual impairment. Or it may lead to a developmental disorder of the brain – “bilateral frontoparietal polymicrogyria”.

Here the cortex folds itself into countless flat gyri; the afflicted suffer from seizures, movement disorders, and retarded mental development. Tumor cells, too, feature faulty adhesion GPCRs, though a causal relationship has yet to be proven in this case. “Fundamental principles of the way in which these receptors work are not yet understood,” says Langenhan. And this is where the work of the new research unit will begin.

Physiology, genetics, pharmacology, biochemistry, structural biology, and pathology: a wide variety of disciplines are represented in the new research unit and will all play their part in shedding light on the signaling behavior of adhesion GPCRs. Developing new drugs is not the primary objective.

“What we do is basic research,” explains Tobias Langenhan. Not until the mechanisms in healthy people are understood can well-founded conclusions be drawn about the pathology, he says. That is not to say, however, that the scientists are completely ignoring any relevance to patients. Langenhan can well envisage the involvement of clinical partners in the potential second period of funding if it goes ahead.

Personal profile

Tobias Langenhan (36) studied medicine at the University of Würzburg from 1997 to 2004. In 2006, he received a doctorate from the Institute of Anatomy with a thesis in neuroanatomy. From 2004 to 2009, Langenhan studied for a Master’s degree and a doctorate at the University of Oxford on a full scholarship from the Wellcome Trust. It was during his doctorate there that he first turned his attention to the way in which adhesion GPCRs work. Since 2009, he has acted as group leader at the Department of Physiology (focus on neurophysiology) at the University of Würzburg.

Contact

Dr. Tobias Langenhan, MSc DPhil (Oxon), T: +49 (0)931 31-88681, tobias.langenhan@uni-wuerzburg.de

DFG research units
A research unit is made up of a team of researchers working together on a research project, according to the DFG’s website. The objective behind supporting research units is to help provide the necessary staff and material resources for close collaboration, usually over six years. Research units often contribute to the establishment of new research directions.

Gunnar Bartsch | Julius-Maximilians-Universität Würzburg
Further information:
http://www.uni-wuerzburg.de

More articles from Health and Medicine:

nachricht Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering

nachricht New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Data use draining your battery? Tiny device to speed up memory while also saving power

14.12.2018 | Power and Electrical Engineering

Tangled magnetic fields power cosmic particle accelerators

14.12.2018 | Physics and Astronomy

In search of missing worlds, Hubble finds a fast evaporating exoplanet

14.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>